Nextcure to present at the jmp securities life sciences conference

Beltsville, md., may 09, 2023 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the jmp securities life sciences conference in new york city on tuesday, may 16th, at 11:30 am et.
NXTC Ratings Summary
NXTC Quant Ranking